在现代免疫抑制治疗下，急性排斥降到最低；然而，病人和长期的同种异体移植物生存并没有同时得到改善。

Acute rejection has been minimised under modern immunosuppression; however, patient and long-term allograft outcomes have not improved concurrently.

youdao

在现代免疫抑制治疗下，急性排斥降到最低；然而，病人和长期的同种异体移植物生存并没有同时得到改善。

Acute rejection has been minimised under modern immunosuppression; however, patient and long-term allograft outcomes have not improved concurrently.

youdao